Arnold I Chin

Title(s)Professor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduct Target Ther. 2023 04 17; 8(1):155. Hu J, Tan P, Ishihara M, Bayley NA, Schokrpur S, Reynoso JG, Zhang Y, Lim RJ, Dumitras C, Yang L, Dubinett SM, Jat PS, Van Snick J, Huang J, Chin AI, Prins RM, Graeber TG, Xu H, Wu L. PMID: 37069149; PMCID: PMC10110583.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients. Case Rep Urol. 2022; 2022:3353268. Qian Z, Chou E, Yang J, Zhang H, Ye H, Liu ST, Chin AI. PMID: 35132367; PMCID: PMC8817887.
      View in: PubMed   Mentions:
    3. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):563-572. Wang L, Smith BA, Balanis NG, Tsai BL, Nguyen K, Cheng MW, Obusan MB, Esedebe FN, Patel SJ, Zhang H, Clark PM, Sisk AE, Said JW, Huang J, Graeber TG, Witte ON, Chin AI, Park JW. PMID: 31871155; PMCID: PMC6955337.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    4. Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis. Precis Clin Med. 2019 Sep; 2(3):140-151. Hu J, Ishihara M, Chin AI, Wu L. PMID: 31598385; PMCID: PMC6770283.
      View in: PubMed   Mentions: 17  
    5. Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient. Oncotarget. 2017 Jul 11; 8(28):45619-45625. Prado K, Zhang KX, Pellegrini M, Chin AI. PMID: 28487492; PMCID: PMC5542213.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. How nerve-sparing technique has been applied to radiotherapy? Asian J Androl. 2016 Nov-Dec; 18(6):898-899. Prado K, Chin AI. PMID: 27453071; PMCID: PMC5109883.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Development and Validation of an Automated Method to Identify Patients Undergoing Radical Cystectomy for Bladder Cancer Using Natural Language Processing. Urol Pract. 2017 Sep; 4(5):365-372. Tan HJ, Clarke R, Chamie K, Kaplan AL, Chin AI, Litwin MS, Saigal CS, Hackbarth AS. PMID: 37592698.
      View in: PubMed   Mentions:
    8. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016 Nov 01; 22(21):5349-5361. Zhang H, Prado K, Zhang KX, Peek EM, Lee J, Wang X, Huang J, Li G, Pellegrini M, Chin AI. PMID: 27189164.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    9. Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol. 2015 Sep; 194(3):626-34. Eggener SE, Badani K, Barocas DA, Barrisford GW, Cheng JS, Chin AI, Corcoran A, Epstein JI, George AK, Gupta GN, Hayn MH, Kauffman EC, Lane B, Liss MA, Mirza M, Morgan TM, Moses K, Nepple KG, Preston MA, Rais-Bahrami S, Resnick MJ, Siddiqui MM, Silberstein J, Singer EA, Sonn GA, Sprenkle P, Stratton KL, Taylor J, Tomaszewski J, Tollefson M, Vickers A, White WM, Lowrance WT. PMID: 25849602; PMCID: PMC4551510.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    10. Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer. J Urol. 2015 Aug; 194(2):547-55. Li DR, Zhang H, Peek E, Wang S, Du L, Li G, Chin AI. PMID: 25748177; PMCID: PMC6371809.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    11. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes. Prostate. 2015 Apr 01; 75(5):463-73. Peek EM, Song W, Zhang H, Huang J, Chin AI. PMID: 25597486.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    12. RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques. Asian J Androl. 2014 Sep-Oct; 16(5):715-9. Wang JG, Huang J, Chin AI. PMID: 24969055; PMCID: PMC4215674.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis. PLoS One. 2014; 9(4):e94793. Zhang H, Chin AI. PMID: 24733360; PMCID: PMC3986223.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    14. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. World J Urol. 2014 Apr; 32(2):385-91. Evers PD, Logan JE, Sills V, Chin AI. PMID: 23756991.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res. 2012; 2(6):745-51. Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. PMID: 23226620; PMCID: PMC3512189.
      View in: PubMed   Mentions: 7  
    16. Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. Urology. 2012 Nov; 80(5):e55-7. Kaplan AL, Margolis DJ, Said J, Chin AI. PMID: 23107414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther. 2011 Jan; 11(1):107-13. Finley DS, Pouliot F, Shuch B, Chin A, Pantuck A, Dekernion JB, Belldegrun AS. PMID: 21166515.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Immunological therapy in urological malignancy: novel combination strategies. Int J Urol. 2011 Feb; 18(2):94-101. Finley DS, Pouliot F, Chin AI, Shuch B, Pantuck AJ, Belldegrun AS, Dekernion JB. PMID: 21073543.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res. 2010 Apr 01; 70(7):2595-603. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G. PMID: 20233880; PMCID: PMC2995454.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    20. Transverse vaginal septum with congenital vesical-vaginal communication and cyclical hematuria. Urology. 2007 Mar; 69(3):575.e5-7. Chin AI, Rutman M, Raz S. PMID: 17382175.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? Rev Urol. 2007; 9(3):124-31. Chin AI, Dave DS, Rajfer J. PMID: 17934569; PMCID: PMC2002502.
      View in: PubMed   Mentions: 1  
    22. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006; 8(1):1-7. Chin AI, Lam JS, Figlin RA, Belldegrun AS. PMID: 16985554; PMCID: PMC1471767.
      View in: PubMed   Mentions: 85  
    23. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J Urol. 2003 Aug; 170(2 Pt 1):380-3. Chin Ai, Ragavendra N, Hilborne L, Gritsch HA. PMID: 12853780.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    24. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 2002 Mar 14; 416(6877):190-4. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. PMID: 11894097.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansAnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Arnold's Networks
    Concepts (156)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California